CLSI eNews - 1 December 2006
(Plain Text Version)
Return to Graphical Version | Search
back issues | Print
all articles
In this issue:
Note on printing single articles: Each selected individual article will
appear at the bottom of this screen...please scroll down to view/print
the selected article.
News
Executive Vice President's Message
CDC Cooperative Agreement: CLSI Advances Vision of Global Growth and Mission to Improve Health Care Worldwide
Essential New CLSI Antimicrobial Susceptibility Testing Updates Scheduled for Release in January 2007
Following the Rules: CLSI Auto10-A document provides a pathway to increased quality and efficiency
CLSI Announces New Corresponding and Associate Active Membership Categories Effective 1 January 2007
Press Releases
Standards Status
ALERT: Proposed-level Document Voting Period Reduced to 60 days
Vote and Deadlines
Recently Approved Documents
Events and Exhibits
Upcoming Events
CLSI Meetings Calendar
Participate in CLSI
Volunteer
New and Sustaining Members
Update Your Subscription
Vote and Deadlines
Toxicology and Drug Testing in the Clinical Laboratory (C52-A2); Principles and Procedures for Blood Cultures (M47-P)
CLSI submits the following for vote as candidate-for-advancement consensus documents. The documents and ballots are available to delegates and alternates of Active and Associate Active member organizations through CLSI Forums.
C52-A2—Toxicology and Drug Testing in the Clinical Laboratory; Approved Guideline—Second Edition
This guideline addresses drug testing in the clinical laboratory, both for clinical and forensic purposes and pertains to both drugs of abuse and other drugs normally encountered and analyzed by hospital laboratories. The guideline discusses the preanalytical, analytical, and postanalytical considerations for specimen collection, methods of analysis, quality assurance, and the reporting and interpretation of results. The deadline for the completed ballot for C52-A2 to be received at the CLSI offices is 29 January 2007.
Second Notice
M47-P—Principles and Procedures for Blood Cultures; Proposed Guideline
This document provides recommendations for the collection, transport, and processing of blood cultures as well as guidance for the recovery of pathogens from blood specimens taken from patients who are suspected of having bacteremia or fungemia. The deadline for the completed ballot for M47-P to be received at the CLSI offices is 29 January 2007.
Under our Administrative Procedures, a CLSI document approved by the area committee at the first level of the consensus process is submitted to delegates as a “candidate-for-advancement” consensus document. This begins the voting and approval period by the delegates.
As a delegate, your vote is to affirm (or reject) the document for advancement as a CLSI document. Please send your completed ballot to the CLSI offices by the above deadline.
In the consensus process, comments are invited at each publication stage. In each edition, the responsible committee includes a summary of comments on the prior edition and its responses to them. Any comments received on a candidate-for-advancement consensus document as a result of delegate voting and consensus review will be addressed by the committee during the document’s advancement.
Find out more about Active and Associate Active membership.
For more information or to contact us directly, please visit www.clsi.org
l ©2006 Clinical and Laboratory Standards
Institute
|